Factors influencing regional myocardial contractile response to inotropic stimulation: Analysis in humans with stable ischemic heart disease

Circulation

Volumn 94, Issue 4, 1996, Pages 643-650

  Skopicki, Hal A ^a   Abraham, Stephen A ^a   Weissman, Neil J ^a   Mukerjee, Anil K ^a   Alpert, Nathaniel M ^a   Fischman, Alan J ^a   Picard, Michael H ^a   Gewirtz, Henry ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

adenosine; coronary disease; echocardiography; myocardial contraction; regional blood flow

Indexed keywords

ADENOSINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; INOTROPIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART CONTRACTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HEART STRESS; HEART VENTRICLE WALL MOTION; HUMAN; INOTROPISM; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REST;

EID: 0029738112     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.4.643     Document Type: Article

References (38)

1. Canty JMJ, Klocke FJ. Reductions in regional myocardial function at rest in conscious dogs with chronically reduced regional coronary artery pressure. Circ Res. 1987;61(suppl II):II-107-II-116.
2. Vatner S. Correlation between acute reductions in myocardial blood flow and function in conscious dogs. Circ Res. 1980;47:201-207.
3. Bache RJ, Schwartz JS. Myocardial blood flow during exercise after gradual coronary occlusion in the dog. Am J Physiol. 1983;245(Heart Circ Physiol 14):H131-H138.
4. Kumada T, Gallagher KP, Shirato K, McKown D, Miller M, Kemper WS, White F, Ross J. Reduction of exercise induced regional myocardial dysfunction by propranolol: studies in a canine model of chronic coronary artery stenosis. Circ Res. 1980;46:190-200.
5. Tomoike H, Ross JJ, Franklin D, Crozarier B, McKown D, Kemper WS. Improvement by propranolol of regional myocardial dysfunction and abnormal coronary flow pattern in conscious dogs with coronary narrowing. Am J Cardiol. 1978;41:689-696.
6. Gewirte H, Olsson RA, Most AS. Role of adenosine in mediating myocardial blood flow response to isoproterenol: observations in closed chest, sedated, domestic swine. Cardiovasc Res. 1986;20:504-511.
7. Suga H, Hisano R, Goto Y, Yamada O, Igarashi Y. Effect of positive inotropic agents on the relation between oxygen consumption and systolic pressure volume area in canine left ventricle. Circ Res. 1983;53:306-318.
8. Gallagher KP, Matsuzaki M, Osakada G, Kemper WS, Ross JR Jr. Effect of exercise on the relationship between myocardial blood flow and systolic wall thickening in dogs with acute coronary stenosis. Circ Res. 1983;52:716-729.
9. Weissman NJ, Levangie MW, Guerrero JL, Weyman AE, Picard MH. The effect of beta blockade on dobutamine stress echocardiography. Am Heart J. 1995;130:248-253.
10. Gewirtz H, Gross SL, Williams DO, Most AS. Contrasting effects of nifedipine and adenosine on regional flow distribution and metabolism distal to a severe coronary arterial stenosis: observations in sedated, closed-chest domestic swine. Circulation. 1984;69:1048-1057.
11. Gewirtz H. Myocardial hibernation: unresolved physiological and clinical issues. Basic Res Cardiol. 1995;90:32-34.
12. Ross JR Jr. Myocardial perfusion-contraction matching: implications for coronary heart disease and hibernation. Circulation. 1991;83:1076-1083.
13. Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117:211-221.
14. Bolli R. Myocardial 'stunning' in man. Circulation. 1992;86:1671-1691.
15. Gewirtz H, Fischman AJ, Abraham SA, Gilson M, Strauss HW, Alpert NM. Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. J Am Coll Cardiol. 1994;23:851-859.
16. Rosenspire KC, Schwaiger M, Magner TJ, Hutchins GD, Sutorik A, Kuhl DE. Metabolic fate of 13-N-ammonia in human and canine blood. J Nucl Med. 1990;31:163-167.
17. Gewirtz H, Fischman A, Alpert N. Validation of K1 parametric images obtained from dynamic 13-NH3 PET images: comparison to KI values obtained with a standard non-linear estimation program. J Nucl Med. 1994;35:77P. Abstract.
18. Weissman N, Nidorf S, Guerro J, Weyman A, Picard M. Optimal stages duration in dobutamine stress echocardiography. J Am Coll Cardiol. 1995;25:605-609.
19. 99mTc-MIBI single photon emission computed tomography. Circulation. 1993;87:345-354.
20. Forster T, McNeill A, Salustri A, Reijs A, el-Said E, Roelandt J, Fioretti P. Simultaneous dobulamine stress echocardiography and technetium-99m isonitrile single-photon emission computed tomography in patients with suspected coronary artery disease. J Am Coll Cardiol. 1993;21:1591-1596.
21. Gallagher KP, Osakada G, Hess OM, Koziol JA, Kemper WS, Ross JRJ. Subepicardial segmental function during coronary stenosis and the role of myocardial fiber orientation. Circ Res. 1982;50:352-359.
22. Buxton DB, Mody FV, Krivokapich J, Phelps ME, Schelbert HR. Quantitative assessment of prolonged metabolic abnormalities in reperfused canine myocardium. Circulation. 1992;85:1842-1856.
23. Liedtke AJ. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis. 1981;23:321-336.
24. Mjos OD, Kjekshus JK, Lekven J. Importance of free fatty acids as a determinant of myocardial oxygen consumption and myocardial ischemic injury during norepinephrine infusion in dogs. J Clin Invest. 1974;53:1290-1299.
25. Fedele FA, Gewirtz H, Capone RJ, Sharaf B, Most AS. Metabolic response to prolonged reduction of myocardial blood flow distal to a severe coronary artery stenosis. Circulation. 1988;78:729-735.
26. Pantley GA, Malone SA, Rhen WS, Anselone CG, Arai A, Bristow J, Bristow JD. Regeneration of myocardial phosphocreatine in pigs despite continued moderate ischemia. Circ Res. 1990;67:1481-1493.
27. Liedtke J, Renstrom B, Nellis S. Correlation between 15-3H]glucose and [U-14C]deoxyglucose as markers of glycolysis in reperfused myocardium. Circ Res. 1992;71:689-700.
28. Vanoverschelde JLJ, Wijns W, Essamri B, Bol A, Robert A, Labar D, Cogneau M, Michel C, Melin JA. Hemodynamic and mechanical determinants of myocardial O2 consumption in normal human heart: effects of dobutamine. Am J Physiol. 1993;265(Heart Circ Physiol 34):H1884-H1892.
29. Topol EJ, Nissen SE. Our preoccupation with coronary luminology: the dissociation between clinical and angiographic findings in ischemic heart disease. Circulation. 1995;92:2333-2342.
30. Picano E, Parodi O, Lattanzi F, Sambuceti G, Andrade MJ, Marzullo P, Giorgetti A, Salvadori P, Marzilli M, Distante A. Assessment of anatomic and physiological severity of single-vessel coronary artery lesions by dipyridamole echocardiography: comparison with positron emission tomography and quantitative arteriography. Circulation. 1994;89;753-761.
31. Demer LL, Gould KL, Goldstein RA, Kirkeeide RL, Mullani NA, Smalling RW, Nishikawa A, Merhige ME. Assessment of coronary artery disease severity by positron emission tomography: comparison with quantitative coronary arteriography in 193 patients. Circulation. 1989;79:825-835.
32. Di Carli M, Czernin J, Hoh C, Gerbaudo V, Brunken R, Huang S, Phelps M, Scheiben H. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation. 1995;91:1944-1951.
33. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert HR, Kuhl D. Noninvasive quantification of regional myocardial blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol. 1990;15:1032-1042.
34. Krivokapich J, Smith GT, Huang SC. 13-N ammonia myocardial imaging at rest and with exercise in normal volunteers: quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation. 1989;80:1328-1337.
35. Schnittger I, Fitzgerald P, Gordon E, Alderman E, Popp R. Computerized quantitative analysis of left ventricular wall motion by two-dimensional echocardiography. Circulation. 1984;70:242-254.
36. Fung AY, Gallagher KP, Buda AJ. The physiological basis of dobutamine as compared with dipyridamole stress interventions in the assessment of critical coronary stenosis. Circulation. 1987;76:943-951.
37. Segar DS, Ryan T, Sawada SG, Johnson M, Feigenbaum H. Pharmacologically induced myocardial ischemia: a comparison of dobutamine and dipyridamole. J Am Soc Echocardiogr. 1995;8:9-14.
38. Zhang J, Path G, Chepuri V, Homans DC, Merkle H, Hendrich K, Ugurbil K, Bache RJ, From AHL. Effects of dobutamine on myocardial blood flow, contractile function, and bioenergetic responses distal to coronary stenosis: implications with regard to dobutamine stress testing. Am Heart J. 1995;129:330-342.